Information  X 
Enter a valid email address

Omega Diagnostics Ord 4P (ODX)

Date Time Source Announcement
01 Dec 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
26 Nov 2021 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
25 Nov 2021 9:06 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Half-year Report
05 Nov 2021 7:00 am
RNS
Notice of Results and Investor Presentation
03 Nov 2021 7:00 am
RNS
Update on CTDA Regulations
01 Nov 2021 3:28 pm
RNS
Exercise of Options and Total Voting Rights
  7:00 am
RNS
Partnership with DAM Health and initial LFT order
19 Oct 2021 12:00 pm
RNS
Exercise of Options and Total Voting Rights
15 Sep 2021 3:26 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
06 Sep 2021 7:00 am
RNS
VISITECT COVID antigen self-test submission update
30 Jul 2021 12:35 pm
RNS
Posting of Annual Report & Accounts &Notice of AGM
27 Jul 2021 7:00 am
RNS
AbC-19 monitors vaccine response to variants
13 Jul 2021 7:01 am
RNS
Final Results
  7:00 am
RNS
Directorate Change
09 Jul 2021 9:08 am
RNS
AbC-19 rapid antibody test performance evaluation
02 Jul 2021 7:00 am
RNS
FDA submission for Emergency Use Authorization
16 Jun 2021 7:00 am
RNS
Notice of Results
15 Jun 2021 10:49 am
RNS
Statement re. Media Comment
10 Jun 2021 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
08 Jun 2021 7:00 am
RNS
Regulatory progress for VISITECT? COVID-19 test
07 Jun 2021 7:00 am
RNS
Progress update
01 Jun 2021 7:00 am
RNS
Positive data for COVID-19 antigen test
06 May 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
05 May 2021 7:00 am
RNS
Positive data for Mologic COVID-19 antigen test
30 Apr 2021 1:30 pm
RNS
Exercise of Options and Total Voting Rights
  7:00 am
RNS
Launch of VISITECT? COVID-19 Antigen & Update
23 Apr 2021 10:30 am
RNS
Director/PDMR Shareholding and Total Voting Rights
19 Apr 2021 7:00 am
RNS
Director/PDMR Shareholding
31 Mar 2021 12:31 pm
RNS
Director/PDMR Shareholding and Total Voting Rights
26 Mar 2021 5:36 pm
RNS
Exercise of Options and Total Voting Rights
  4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
22 Mar 2021 7:00 am
RNS
CE-Mark: Mologic COVID19 lateral flow antigen test
19 Mar 2021 1:15 pm
RNS
Exercise of Options and Total Voting Rights
15 Mar 2021 5:28 pm
RNS
Statement re. Government press release
  7:00 am
RNS
UK Public Sector Contract disclosure
08 Mar 2021 7:00 am
RNS
Grant of Options
02 Mar 2021 7:00 am
RNS
Contract with Screen4
24 Feb 2021 7:00 am
RNS
UK-RTC statement on AbC-19TM rapid antibody test
19 Feb 2021 1:45 pm
RNS
Director/PDMR Shareholding
18 Feb 2021 10:00 am
RNS
Director/PDMR Shareholding
16 Feb 2021 7:00 am
RNS
AbC-19TM rapid antibody test performance data
15 Feb 2021 7:00 am
RNS
Director/PDMR Shareholding
11 Feb 2021 9:00 am
RNS
Price Monitoring Extension
  7:01 am
RNS
UK Government contract and trading update
  7:00 am
RNS
Directorate Change
08 Feb 2021 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Statement re Media Comment
02 Feb 2021 8:45 am
RNS
Exercise of Options and Total Voting Rights
28 Jan 2021 1:15 pm
RNS
Exercise of Options and Total Voting Rights

a d v e r t i s e m e n t